How much revenue did Generix Group generate this year?
Generix Group has achieved a revenue of 97.92 M EUR this year.
Generix Group Revenue 2024
Generix Group Revenue
97.92 M EUR
Ticker
GENX.PA
ISIN
FR0010501692
WKN
A0MYAC
In 2024, Generix Group's sales reached 97.92 M EUR, a 6.67% difference from the 91.8 M EUR sales recorded in the previous year.
The Generix Group Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 99.75 | 71,86 |
| 2025e | 98.66 | 72,65 |
| 2024e | 97.92 | 73,20 |
| 2023e | 91.8 | 78,08 |
| 2022 | 84.5 | 84,82 |
| 2021 | 80.26 | 82,96 |
| 2020 | 81.1 | 77,85 |
| 2019 | 76.64 | 69,42 |
| 2018 | 70.29 | 67,75 |
| 2017 | 63 | 65,58 |
| 2016 | 58.39 | 65,57 |
| 2015 | 53.67 | 74,72 |
| 2014 | 49.4 | 75,65 |
| 2013 | 63.13 | 75,56 |
| 2012 | 64.27 | 70,78 |
| 2011 | 66.2 | 67,98 |
| 2010 | 68.57 | 70,23 |
| 2009 | 67.62 | 70,51 |
| 2008 | 55.54 | 75,14 |
| 2007 | 6.42 | 68,38 |
| 2006 | 23.52 | 79,80 |
| 2005 | 19.42 | 79,15 |
| 2004 | 16.2 | 73,21 |
| 2003 | 17.27 | 76,43 |
Generix Group Revenue, EBIT, Net Income FR0010501692 · A0MYAC
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Generix Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Generix Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Generix Group’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Generix Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Generix Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Generix Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Generix Group’s growth potential.
Generix Group Revenue, EBIT and net profit per share
| Date | Generix Group Revenue | Generix Group EBIT | Generix Group Net Income |
|---|---|---|---|
| 2026e | 99.75 M undefined | 8.64 M undefined | 4.23 M undefined |
| 2025e | 98.66 M undefined | 8.31 M undefined | 4.27 M undefined |
| 2024e | 97.92 M undefined | 8.16 M undefined | 4.39 M undefined |
| 2023e | 91.8 M undefined | 6.12 M undefined | 3.47 M undefined |
| 2022 | 84.5 M undefined | 6.25 M undefined | 3.41 M undefined |
| 2021 | 80.26 M undefined | 7.11 M undefined | 4.22 M undefined |
| 2020 | 81.1 M undefined | 9.47 M undefined | 3.41 M undefined |
| 2019 | 76.64 M undefined | 5.31 M undefined | 2.29 M undefined |
| 2018 | 70.29 M undefined | 2.16 M undefined | 565,000 undefined |
| 2017 | 63 M undefined | 1.47 M undefined | -181,000 undefined |
| 2016 | 58.39 M undefined | 2.29 M undefined | 1.24 M undefined |
| 2015 | 53.67 M undefined | 3.28 M undefined | 843,000 undefined |
| 2014 | 49.4 M undefined | 3.54 M undefined | 3.7 M undefined |
| 2013 | 63.13 M undefined | 3.13 M undefined | 1.63 M undefined |
| 2012 | 64.27 M undefined | -870,000 undefined | -2.11 M undefined |
| 2011 | 66.2 M undefined | -5.2 M undefined | -5.7 M undefined |
| 2010 | 68.57 M undefined | -3.47 M undefined | -2.76 M undefined |
| 2009 | 67.62 M undefined | -5.22 M undefined | -3.68 M undefined |
| 2008 | 55.54 M undefined | 3.12 M undefined | 1.42 M undefined |
| 2007 | 6.42 M undefined | 410,000 undefined | 300,000 undefined |
| 2006 | 23.52 M undefined | 1.7 M undefined | 2.58 M undefined |
| 2005 | 19.42 M undefined | -660,000 undefined | 90,000 undefined |
| 2004 | 16.2 M undefined | -3.3 M undefined | -3.28 M undefined |
| 2003 | 17.27 M undefined | -3.01 M undefined | -1.75 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2003 | 17.27 M EUR | -3.01 M EUR | -1.75 M EUR |
| 2004 | 16.2 M EUR | -3.3 M EUR | -3.28 M EUR |
| 2005 | 19.42 M EUR | -660,000 EUR | 90,000 EUR |
| 2006 | 23.52 M EUR | 1.7 M EUR | 2.58 M EUR |
| 2007 | 6.42 M EUR | 410,000 EUR | 300,000 EUR |
| 2008 | 55.54 M EUR | 3.12 M EUR | 1.42 M EUR |
| 2009 | 67.62 M EUR | -5.22 M EUR | -3.68 M EUR |
| 2010 | 68.57 M EUR | -3.47 M EUR | -2.76 M EUR |
| 2011 | 66.2 M EUR | -5.2 M EUR | -5.7 M EUR |
| 2012 | 64.27 M EUR | -870,000 EUR | -2.11 M EUR |
| 2013 | 63.13 M EUR | 3.13 M EUR | 1.63 M EUR |
| 2014 | 49.4 M EUR | 3.54 M EUR | 3.7 M EUR |
| 2015 | 53.67 M EUR | 3.28 M EUR | 843,000 EUR |
| 2016 | 58.39 M EUR | 2.29 M EUR | 1.24 M EUR |
| 2017 | 63 M EUR | 1.47 M EUR | -181,000 EUR |
| 2018 | 70.29 M EUR | 2.16 M EUR | 565,000 EUR |
| 2019 | 76.64 M EUR | 5.31 M EUR | 2.29 M EUR |
| 2020 | 81.1 M EUR | 9.47 M EUR | 3.41 M EUR |
| 2021 | 80.26 M EUR | 7.11 M EUR | 4.22 M EUR |
| 2022 | 84.5 M EUR | 6.25 M EUR | 3.41 M EUR |
| 2023e | 91.8 M EUR | 6.12 M EUR | 3.47 M EUR |
| 2024e | 97.92 M EUR | 8.16 M EUR | 4.39 M EUR |
| 2025e | 98.66 M EUR | 8.31 M EUR | 4.27 M EUR |
| 2026e | 99.75 M EUR | 8.64 M EUR | 4.23 M EUR |
Generix Group stock margins FR0010501692 · A0MYAC
The Generix Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Generix Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Generix Group.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Generix Group's sales revenue. A higher gross margin percentage indicates that the Generix Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Generix Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Generix Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Generix Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Generix Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Generix Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Generix Group Margin History
| Generix Group Gross margin | Generix Group Profit margin | Generix Group EBIT margin | Generix Group Profit margin |
|---|---|---|---|
| 2026e | 84.82 % | 8.66 % | 4.24 % |
| 2025e | 84.82 % | 8.43 % | 4.33 % |
| 2024e | 84.82 % | 8.33 % | 4.49 % |
| 2023e | 84.82 % | 6.67 % | 3.78 % |
| 2022 | 84.82 % | 7.39 % | 4.04 % |
| 2021 | 82.96 % | 8.86 % | 5.26 % |
| 2020 | 77.85 % | 11.67 % | 4.2 % |
| 2019 | 69.42 % | 6.93 % | 2.98 % |
| 2018 | 67.75 % | 3.08 % | 0.8 % |
| 2017 | 65.58 % | 2.33 % | -0.29 % |
| 2016 | 65.57 % | 3.92 % | 2.12 % |
| 2015 | 74.72 % | 6.11 % | 1.57 % |
| 2014 | 75.65 % | 7.17 % | 7.49 % |
| 2013 | 75.56 % | 4.96 % | 2.58 % |
| 2012 | 70.78 % | -1.35 % | -3.28 % |
| 2011 | 67.98 % | -7.85 % | -8.61 % |
| 2010 | 70.23 % | -5.06 % | -4.03 % |
| 2009 | 70.51 % | -7.72 % | -5.44 % |
| 2008 | 75.14 % | 5.62 % | 2.56 % |
| 2007 | 68.38 % | 6.39 % | 4.67 % |
| 2006 | 79.8 % | 7.23 % | 10.97 % |
| 2005 | 79.15 % | -3.4 % | 0.46 % |
| 2004 | 73.21 % | -20.37 % | -20.25 % |
| 2003 | 76.43 % | -17.43 % | -10.13 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2003 | 76.43 % | -17.43 % | -10.13 % |
| 2004 | 73.21 % | -20.37 % | -20.25 % |
| 2005 | 79.15 % | -3.4 % | 0.46 % |
| 2006 | 79.8 % | 7.23 % | 10.97 % |
| 2007 | 68.38 % | 6.39 % | 4.67 % |
| 2008 | 75.14 % | 5.62 % | 2.56 % |
| 2009 | 70.51 % | -7.72 % | -5.44 % |
| 2010 | 70.23 % | -5.06 % | -4.03 % |
| 2011 | 67.98 % | -7.85 % | -8.61 % |
| 2012 | 70.78 % | -1.35 % | -3.28 % |
| 2013 | 75.56 % | 4.96 % | 2.58 % |
| 2014 | 75.65 % | 7.17 % | 7.49 % |
| 2015 | 74.72 % | 6.11 % | 1.57 % |
| 2016 | 65.57 % | 3.92 % | 2.12 % |
| 2017 | 65.58 % | 2.33 % | -0.29 % |
| 2018 | 67.75 % | 3.08 % | 0.8 % |
| 2019 | 69.42 % | 6.93 % | 2.98 % |
| 2020 | 77.85 % | 11.67 % | 4.2 % |
| 2021 | 82.96 % | 8.86 % | 5.26 % |
| 2022 | 84.82 % | 7.39 % | 4.04 % |
| 2023e | 84.82 % | 6.67 % | 3.78 % |
| 2024e | 84.82 % | 8.33 % | 4.49 % |
| 2025e | 84.82 % | 8.43 % | 4.33 % |
| 2026e | 84.82 % | 8.66 % | 4.24 % |
Generix Group Aktienanalyse
What does Generix Group do?
Generix Group SA is a leading provider of software solutions for supply chain management and e-commerce. The company was founded in 1990 in France and has its headquarters in Paris. It employs over 1,000 employees and operates in Europe, North America, and Asia. Its business model is based on the development and sale of software solutions for optimizing supply chains and business processes. They offer a range of products including warehouse management systems, transport management systems, supply chain planning, electronic data interchange, and e-commerce platforms. The company is segmented into three business areas: supply chain collaboration, supply chain execution, and e-commerce. They offer solutions for collaboration between suppliers, customers, and partners, as well as inventory management, transportation, and delivery management. They also have platforms for online sales and distribution that cater to B2B and B2C companies. Some of their key products include collaborative supply chain management, warehouse management, and transportation management. They also develop innovative technologies such as robotic warehouses and cloud platforms for e-commerce. They are pioneers in artificial intelligence and machine learning, working closely with universities and research institutions. Overall, Generix Group SA has a strong position in the supply chain management and e-commerce solutions market, offering a wide range of products tailored to various industries. With their focus on innovation and technology, they are well positioned for future success. Generix Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Generix Group's Sales Figures
The sales figures of Generix Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Generix Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Generix Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Generix Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Generix Group stock
How much was the turnover of the company Generix Group compared to the previous year?
The revenue of Generix Group has increased by 6.67% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Generix Group?
The revenue of Generix Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Generix Group measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Generix Group so important for investors?
The revenue of Generix Group is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Generix Group pay?
Over the past 12 months, Generix Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Generix Group is expected to pay a dividend of 0 EUR.
What is the dividend yield of Generix Group?
The current dividend yield of Generix Group is .
When does Generix Group pay dividends?
Generix Group pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Generix Group?
Generix Group paid dividends every year for the past 0 years.
What is the dividend of Generix Group?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Generix Group located?
Generix Group is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von Generix Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Generix Group from 7/31/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.
When did Generix Group pay the last dividend?
The last dividend was paid out on 7/31/2024.
What was the dividend of Generix Group in the year 2023?
In the year 2023, Generix Group distributed 0 EUR as dividends.
In which currency does Generix Group pay out the dividend?
The dividends of Generix Group are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Generix Group
Our stock analysis for Generix Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Generix Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Generix Group Revenue
- Generix Group Net Income
- Generix Group P/E
- Generix Group P/S
- Generix Group EBIT
- Generix Group Dividend
- Generix Group Stocks
- Generix Group Market capitalization
- Generix Group Debt
- Generix Group Liabilities
- Generix Group Equity
- Generix Group AAQS
- Generix Group Employees
- Generix Group ROE
- Generix Group ROA
- Generix Group ROCE
